common.study.topics.clinical

Cortisone Injection and Splinting for Trigger Finger

common.study.values.description

Effectiveness of Cortisone Injection and Splinting for Trigger Finger

Trigger finger has a prevalence rate of up to 3%. There are many approaches available to manage this condition. While corticosteroid injection is widely accepted as the most common first-line treatment, its superiority over splint treatment has not been established. This study aims to test the effectiveness of cortisone injections, splint and cortisone+splint to resolve symptoms.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Splint

Custom made splint

Drug - Betamethasone

Corticosteroid Injection Brand name of the drug: Celestone Soluspan Dosage: 6 mg/ml

Combination Product - Splint + Cortico-steroid injection

Splint + Cortico-steroid injection given in combination

participant.views.study.view.additional

participant.views.study.view.scientific-title

Effectiveness of Cortisone Injection and Splinting for Trigger Finger: A Prospective Randomized Controlled Trial

common.study.values.clinical-trial-id

NCT03156829

participant.views.study.view.id

xboBja